These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1900608)

  • 1. The "plateau effect" of cis-platinum-induced hearing loss.
    Myers SF; Blakley BW; Schwan S; Rintelmann WF; Mathog RH
    Otolaryngol Head Neck Surg; 1991 Jan; 104(1):122-7. PubMed ID: 1900608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. cis-platinum ototoxicity in children.
    Weatherly RA; Owens JJ; Catlin FI; Mahoney DH
    Laryngoscope; 1991 Sep; 101(9):917-24. PubMed ID: 1886439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical study of the ototoxicity of cisplatin].
    Basterra J; Iranzo C; Marco J
    An Otorrinolaringol Ibero Am; 1985; 12(2):167-72. PubMed ID: 4039901
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of the hearing loss associated with cis-platinum treatment by high-frequency audiometry.
    Kujansuu E; Rahko T; Punnonen R; Karma P
    Gynecol Oncol; 1989 Jun; 33(3):321-2. PubMed ID: 2722056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisplatin-induced ototoxicity: audiometric findings and experimental cochlear pathology.
    Böheim K; Bichler E
    Arch Otorhinolaryngol; 1985; 242(1):1-6. PubMed ID: 4041173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Audiometric patterns in ototoxicity of intra-arterial Cisplatin chemoradiation in patients with locally advanced head and neck cancer.
    Zuur CL; Simis YJ; Lansdaal PE; Rasch CR; Tange RA; Balm AJ; Dreschler WA
    Audiol Neurootol; 2006; 11(5):318-30. PubMed ID: 16983183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid onset hearing loss after Cisplatinum therapy: case reports and literature review.
    Chapman P
    J Laryngol Otol; 1982 Feb; 96(2):159-62. PubMed ID: 7199070
    [No Abstract]   [Full Text] [Related]  

  • 8. Sudden bilateral sensorineural hearing loss after intravenous cocaine injection: a case report and review of the literature.
    Stenner M; Stürmer K; Beutner D; Klussmann JP
    Laryngoscope; 2009 Dec; 119(12):2441-3. PubMed ID: 19806646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of hearing loss resulting from cis-platinum therapy.
    Blakley BW; Myers SF
    Otolaryngol Head Neck Surg; 1993 Sep; 109(3 Pt 1):385-91. PubMed ID: 8414553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose cisplatin treatment: hearing loss and plasma concentrations.
    Laurell G; Jungnelius U
    Laryngoscope; 1990 Jul; 100(7):724-34. PubMed ID: 2362532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute onset deafness in a 4-year-old girl after a single infusion of cis-platinum.
    Bührer C; Weinel P; Sauter S; Reiter A; Riehm H; Laszig R
    Pediatr Hematol Oncol; 1990; 7(2):145-8. PubMed ID: 2206855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platinum compound-related ototoxicity in children: long-term follow-up reveals continuous worsening of hearing loss.
    Bertolini P; Lassalle M; Mercier G; Raquin MA; Izzi G; Corradini N; Hartmann O
    J Pediatr Hematol Oncol; 2004 Oct; 26(10):649-55. PubMed ID: 15454836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythromycin associated hearing loss in a patient with prior cis-platinum induced ototoxicity.
    Wallach PM; Love SR; Fiorica JV; Hoffman MS; Flannery MT
    J Fla Med Assoc; 1992 Dec; 79(12):821-2. PubMed ID: 1474367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased hearing after combined modality therapy for head and neck cancer.
    Pearson SE; Meyer AC; Adams GL; Ondrey FG
    Am J Otolaryngol; 2006; 27(2):76-80. PubMed ID: 16500467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ototoxicity of high-dose cisplatin by bolus administration in patients with advanced cancers and normal hearing.
    Kopelman J; Budnick AS; Sessions RB; Kramer MB; Wong GY
    Laryngoscope; 1988 Aug; 98(8 Pt 1):858-64. PubMed ID: 3398663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cis-platinum ototoxicity: clinical experience and temporal bone histopathology.
    Strauss M; Towfighi J; Lord S; Lipton A; Harvey HA; Brown B
    Laryngoscope; 1983 Dec; 93(12):1554-9. PubMed ID: 6685804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. cis-platinum ototoxicity in children.
    Pasic TR; Dobie RA
    Laryngoscope; 1991 Sep; 101(9):985-91. PubMed ID: 1886448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of high-frequency audiometry increases the diagnosis of asymptomatic hearing loss in pediatric patients treated with cisplatin-based chemotherapy.
    Abujamra AL; Escosteguy JR; Dall'Igna C; Manica D; Cigana LF; Coradini P; Brunetto A; Gregianin LJ
    Pediatr Blood Cancer; 2013 Mar; 60(3):474-8. PubMed ID: 22744939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tone-burst and click-evoked otoacoustic emissions in subjects with hearing loss above 0.25, 0.5, and 1 kHz.
    Jedrzejczak WW; Kochanek K; Trzaskowski B; Pilka E; Skarzynski PH; Skarzynski H
    Ear Hear; 2012; 33(6):757-67. PubMed ID: 22710662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cisplatin ototoxicity. A clinical study].
    Schröder M; Laskawi R; Stennert E; Kühnle H; Thiele FW
    Laryngol Rhinol Otol (Stuttg); 1986 Feb; 65(2):86-9. PubMed ID: 3959692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.